Background Psychosomatic disorders, characterized by physical symptoms exacerbated or caused by psychological factors, present significant challenges in clinical management. Hypnotherapy, a therapeutic technique that induces a trance-like state to promote focused attention and suggestibility, has shown promise in treating such conditions. This scoping review explores the existing evidence on hypnotherapy’s efficacy in managing psychosomatic disorders. Method A systematic search was conducted across PubMed, PsycINFO, Scopus, Web of Science, Google Scholar, and grey literature for studies published between 2019 and 2025. Keywords included hypnotherapy, psychosomatic disorders, and names of all psychosomatic disorders like asthma, fibromyalgia, and etc. Both randomized controlled trials (RCTs) and observational studies were included, and non professional hypnosis was excluded. Results Thirty studies met the inclusion criteria, covering conditions such as irritable bowel syndrome (IBS), chronic pain, diabetes, vaginismus. According to a study, hypnotherapy can noticeably lessen anxiety and depression in patients after a few sessions, 1 improve their quality of life 2 and alleviate rumination and other psychological symptoms. 3 Conclusion Hypnotherapy appears to be a viable adjunctive treatment for psychosomatic disorders, though further high-quality research is needed to establish standardized protocols and long-term efficacy.
Shima Maserrat (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: